Anaesthesiology for NEET-PG
Local Anaesthetic Toxicity for NEET-PG
Local anaesthetic systemic toxicity is a potentially fatal reaction from excessive plasma concentrations of local anaesthetic, usually after accidental intravascular injection or exceeding the maximum safe dose. For NEET-PG, the crucial points are the mechanism, the progression of central nervous system then cardiovascular signs, the maximum safe doses, and the role of intravenous lipid emulsion rescue. Local anaesthetics block voltage-gated sodium channels, and when systemic levels rise, the central nervous system is affected first, producing circumoral tingling, a metallic taste, tinnitus, agitation, and seizures, followed by central nervous system depression. At higher levels the cardiovascular system is affected, with hypotension, conduction block, arrhythmias, and cardiac arrest, and bupivacaine is the most cardiotoxic agent because it binds sodium channels avidly and is hard to resuscitate. Prevention relies on aspirating before injection, using incremental dosing, staying within maximum doses, and adding adrenaline to slow absorption. Toxicity management follows the standard airway, breathing, and circulation approach with seizure control, and the specific antidote is intravenous lipid emulsion, which acts as a lipid sink to sequester the drug. Knowing the CNS-first then cardiac progression, bupivacaine cardiotoxicity, the maximum safe doses of lidocaine with and without adrenaline, and lipid emulsion rescue are consistent exam anchors.
MedNext Academy | 3 min read
Local Anaesthetic Toxicity for NEET-PG
Local anaesthetic systemic toxicity is a potentially fatal reaction from excessive plasma concentrations of local anaesthetic, usually after accidental intravascular injection or exceeding the maximum safe dose. For NEET-PG, the crucial points are the mechanism, the progression of central nervous system then cardiovascular signs, the maximum safe doses, and the role of intravenous lipid emulsion rescue. Local anaesthetics block voltage-gated sodium channels, and when systemic levels rise, the central nervous system is affected first, producing circumoral tingling, a metallic taste, tinnitus, agitation, and seizures, followed by central nervous system depression. At higher levels the cardiovascular system is affected, with hypotension, conduction block, arrhythmias, and cardiac arrest, and bupivacaine is the most cardiotoxic agent because it binds sodium channels avidly and is hard to resuscitate. Prevention relies on aspirating before injection, using incremental dosing, staying within maximum doses, and adding adrenaline to slow absorption. Toxicity management follows the standard airway, breathing, and circulation approach with seizure control, and the specific antidote is intravenous lipid emulsion, which acts as a lipid sink to sequester the drug. Knowing the CNS-first then cardiac progression, bupivacaine cardiotoxicity, the maximum safe doses of lidocaine with and without adrenaline, and lipid emulsion rescue are consistent exam anchors.
Local anaesthetic systemic toxicity is a potentially fatal reaction from excessive plasma concentrations of local anaesthetic, usually after accidental intravascular injection or exceeding the maximum safe dose. For NEET-PG, the crucial points are the mechanism, the progression of central nervous system then cardiovascular signs, the maximum safe doses, and the role of intravenous lipid emulsion rescue. Local anaesthetics block voltage-gated sodium channels, and when systemic levels rise, the central nervous system is affected first, producing circumoral tingling, a metallic taste, tinnitus, agitation, and seizures, followed by central nervous system depression. At higher levels the cardiovascular system is affected, with hypotension, conduction block, arrhythmias, and cardiac arrest, and bupivacaine is the most cardiotoxic agent because it binds sodium channels avidly and is hard to resuscitate. Prevention relies on aspirating before injection, using incremental dosing, staying within maximum doses, and adding adrenaline to slow absorption. Toxicity management follows the standard airway, breathing, and circulation approach with seizure control, and the specific antidote is intravenous lipid emulsion, which acts as a lipid sink to sequester the drug. Knowing the CNS-first then cardiac progression, bupivacaine cardiotoxicity, the maximum safe doses of lidocaine with and without adrenaline, and lipid emulsion rescue are consistent exam anchors.
Key points
- **Mechanism:** Local anaesthetics block voltage-gated sodium channels. Systemic toxicity follows intravascular injection or exceeding the maximum safe dose.
- **CNS first:** Early signs are circumoral tingling, metallic taste, tinnitus, visual disturbance, and agitation, progressing to seizures.
- **Then cardiovascular:** Higher levels cause hypotension, conduction block, ventricular arrhythmias, and cardiac arrest as the later, more dangerous phase.
- **Bupivacaine cardiotoxicity:** Bupivacaine is the most cardiotoxic agent because it binds sodium channels tightly, causing refractory arrhythmias and difficult resuscitation.
- **Maximum lidocaine dose:** Lidocaine maximum is about 3 mg per kg plain and about 7 mg per kg with adrenaline, which slows systemic absorption.
- **Adrenaline role:** Adding adrenaline causes vasoconstriction, reducing systemic absorption, prolonging block, and raising the maximum safe dose.
- **Prevention:** Aspirate before injection, use incremental dosing, avoid intravascular placement, and never exceed weight-based maximum doses.
- **Lipid emulsion rescue:** Intravenous 20 percent lipid emulsion is the specific antidote, acting as a lipid sink to draw drug away from cardiac tissue.
- **Resuscitation priority:** Manage airway, breathing, and circulation, control seizures with benzodiazepines, and start lipid emulsion early in severe toxicity.
- **Avoid certain drugs:** During resuscitation avoid vasopressin, calcium channel blockers, beta blockers, and use reduced adrenaline doses per guidelines.
- **High-risk sites:** Highly vascular sites and large-volume blocks increase absorption and toxicity risk, so vigilance and monitoring are essential.
Frequently Asked Questions
How does local anaesthetic toxicity progress?
Central nervous system signs appear first, such as tingling, metallic taste, tinnitus, and seizures, followed by cardiovascular collapse with arrhythmias and arrest.
Which local anaesthetic is most cardiotoxic?
Bupivacaine is the most cardiotoxic because it binds cardiac sodium channels tightly, producing refractory arrhythmias and difficult resuscitation.
What is the antidote for local anaesthetic systemic toxicity?
Intravenous 20 percent lipid emulsion is the specific antidote. It acts as a lipid sink, sequestering the drug away from cardiac tissue.
Why is adrenaline added to local anaesthetics?
Adrenaline causes vasoconstriction that slows systemic absorption, prolongs the block, and raises the maximum safe dose that can be given.
What is the maximum safe dose of lidocaine?
Lidocaine is roughly 3 mg per kg without adrenaline and about 7 mg per kg with adrenaline, which reduces its absorption.
Continue reading
NEET-PGComplete NEET-PG guide
Review the exam pattern, preparation and resources.
Practise Anaesthesiology for NEET-PG
Explore clinician-written learning resources, structured revision and practice across the MedNext platform.
See plans